Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence.

Tytuł:
Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence.
Autorzy:
Daly CJ; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, NY, USA.
Verrall K; Pharmacy Quality and Medication Therapy Management, Independent Health, Buffalo, NY, USA.
Jacobs DM; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, NY, USA.
Źródło:
Journal of pharmacy practice [J Pharm Pract] 2021 Oct; Vol. 34 (5), pp. 694-702. Date of Electronic Publication: 2019 Dec 30.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: <2002-> : Thousand Oaks, Calif. : Sage Publications
Original Publication: [Philadelphia, PA] : W.B. Saunders, [1988]-
MeSH Terms:
Angiotensin Receptor Antagonists*
Pharmacists*
Aged ; Angiotensin-Converting Enzyme Inhibitors ; Humans ; Managed Care Programs ; Medicare ; Medication Adherence ; United States
Contributed Indexing:
Keywords: adherence; community pharmacy; community pharmacy services; coordination of care; third-party collaboration
Substance Nomenclature:
0 (Angiotensin Receptor Antagonists)
0 (Angiotensin-Converting Enzyme Inhibitors)
Entry Date(s):
Date Created: 20191231 Date Completed: 20211005 Latest Revision: 20220427
Update Code:
20240104
DOI:
10.1177/0897190019896505
PMID:
31884874
Czasopismo naukowe
Background: Nonadherence to medications is a concern due to adverse outcomes and higher costs of care. The Centers for Medicare and Medicaid Services has made adherence a key measurement for Star ratings.
Objective: To evaluate the impact of a collaborative pilot program between a third-party payer, local pharmacy organization, and academic institution focusing on improving medication adherence with community pharmacies.
Methods: Twenty-five community pharmacies implemented adherence-based interventions in patients ≥65 years old, who were Medicare Advantage Plan members, taking targeted medications (statins, oral diabetic medications, angiotensin-converting enzyme inhibitors [ACE-Is] and angiotensin receptor blockers [ARBs]). Outcome measures were (1) pharmacy intervention completion rate, (2) type of adherence interventions, (3) change in the proportion of days covered (PDC) following pharmacist intervention based on adherence group, and (4) nonadherence barriers.
Results: A total of 1263 interventions met the eligibility criteria, and common interventions included explaining the benefit of the medication (n = 453, 35.9%) and provider follow-up (n = 109, 8.6%). Among nonadherent subjects who became adherent, the mean PDC increased by 14% (74%-88%, P < .0001), with a 12% decrease in mean PDC score in the nonadherent who remained nonadherent group (71%-58%, P < .0001). Common patient barriers for nonadherence were forgetfulness (n = 451, 35.7%) and denial (n = 84, 6.7%). System and therapeutic barriers included complexity (n = 155, 12.3%) and adverse side effects (n = 42, 3.3%).
Conclusion: This collaborative effort successfully implemented a community pharmacist-led adherence intervention in 25 independent pharmacies. Our findings highlight increased interactions with patients and in some cases improved adherence measures. Future research must include implementation outcomes in order to effectively implement these interventions in the community pharmacy setting.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies